Target Ovarian Cancer Revenue and Competitors

London, UK

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Target Ovarian Cancer's estimated annual revenue is currently $7.5M per year.(i)
  • Target Ovarian Cancer's estimated revenue per employee is $98,684

Employee Data

  • Target Ovarian Cancer has 76 Employees.(i)
  • Target Ovarian Cancer grew their employee count by 4% last year.

Target Ovarian Cancer's People

NameTitleEmail/Phone
1
Chief ExecutiveReveal Email/Phone
2
Head Policy and CampaignsReveal Email/Phone
3
Finance OfficerReveal Email/Phone
4
Head Primary Care DevelopmentReveal Email/Phone
5
Director DevelopmentReveal Email/Phone
6
Senior Events and Support OfficerReveal Email/Phone
7
Director Finance & Corporate ServicesReveal Email/Phone
8
Interim Director CommunicationsReveal Email/Phone
9
Supporter Engagement OfficerReveal Email/Phone
10
Deputy Director ServicesReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M7410%N/AN/A
#2
$7.5M100-6%N/AN/A
#3
$35M27589%N/AN/A
#4
$15M37320%N/AN/A
#5
$1.7M329-3%N/AN/A
#6
$3.5M12234%N/AN/A
#7
$7.5M174-6%N/AN/A
#8
$7.5M597%N/AN/A
#9
N/A29-24%N/AN/A
#10
$3.5M63-7%N/AN/A
Add Company

What Is Target Ovarian Cancer?

Target Ovarian Cancer is the UK's leading ovarian cancer charity. We work to: - improve early diagnosis - fund life-saving research - provide much-needed support to women with ovarian cancer We're the only charity fighting ovarian cancer on all three of these fronts, across all four nations of the UK. Ovarian cancer can be devastating. But there is hope – Target Ovarian Cancer. We work with women, family members and health professionals to ensure we target the areas that matter most for those living with ovarian cancer. Target Ovarian Cancer is a company limited by guarantee, registered in England and Wales (No. 6619981). Registered office: 30 Angel Gate, London EC1V 2PT. Registered charity numbers 1125038 (England and Wales) and SC042920 (Scotland).

keywords:N/A

N/A

Total Funding

76

Number of Employees

$7.5M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Target Ovarian Cancer News

2022-04-17 - Hidden Vulnerability in Ovarian and Uterine Cancers Identified

“Some genetic dependencies of ovarian cancer are difficult to target with drugs, but we showed we can actually use a protein to target XPR1 and...

2022-04-17 - New combinatorial strategies to treat ovarian cancer

Researchers have found how ovarian cancer tumours defy immunotherapy, identifying new molecular targets that might boost immune response.

2022-03-30 - Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with ...

But the biotech hopes a new win in a broad ovarian cancer patient population—and a possible FDA nod—will put its med in a better position alongside Big...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.2M76-16%N/A
#2
$11M7619%N/A
#3
$11M76-27%N/A
#4
$17.8M767%N/A
#5
$19.1M764%N/A